uploads///

ACB, CRON, and CGC Get Ratings Coverage from BofA Merrill Lynch

By

Updated

Analysts’ ratings

Early on April 17, Bank of America Merrill Lynch initiated coverage on three cannabis stocks. Aurora Cannabis (ACB) received a “buy” recommendation and a target price of 15 Canadian dollars or $11 to be achieved over the next 12 months. Based on the closing on April 16, the target price leaves an upside in excess of 20%. Aurora Cannabis was trading 2.4% higher when the US market (MJ) opened, while Tilray (TLRY) rose 1.3%.

Article continues below advertisement

Cronos Group and Canopy Growth

Bank of America Merrill Lynch also initiated coverage on Cronos Group (CRON) with an “underperform” recommendation. The rating is considered to be between a “hold” and a “sell.” Bank of America Merrill Lynch also set a target price of 17 Canadian dollars or $13. Cronos Group was already trading well above the target price at 21 Canadian dollars. Cronos Group was trading 1.5% lower in the US market early on April 17.

Bank of America Merrill Lynch also initiated coverage on Canopy Growth (WEED) with a “buy” rating. Canopy Growth’s target price was set at 70 Canadian dollars or $52. Canopy Growth closed at 55.5 Canadian dollars on April 16 with a potential upside of 26% in the Canadian market and ~20% in the US market. In the US market, Canopy Growth closed at $43.3. Canopy Growth was trading 3.9% higher in the US market early on April 17.

Advertisement

More From Market Realist